PROCEPT BioRobotics Market Sentiment

SPY752.33−2.21%QQQ685.80−4.13%BTC/USD76,650.03−1.48%DIA516.07−1.28%GLD355.45−3.56%TLT81.63+0.17%

Premium Services

PROCEPT BioRobotics Corp

PRCTNASDAQ

Trade with Public

$19.10

-1.20-5.91%

Last update: Oct 30, 2:23 PM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Earnings: Q3 2026 Earnings in 5 days from now on Wed Nov 4th, after the market close

Conference Call: Conference call scheduled in 5 days at 4:30 PM

Click to view the webcast

PROCEPT BioRobotics Market Sentiment - Benzinga

PROCEPT BioRobotics Market Sentiment

Market sentiment signals for PROCEPT BioRobotics (PRCT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▼ 13.5% short float

Options Flow▲ 0.91 P/C ratio

Insider Activity— N/A

Analyst Consensus

Overweight

15 analysts

Options Flow (P/C)

0.91

More calls — Bullish

11 calls · 10 puts

Avg Consensus PT

$34

+78.9%

Highest Price Target

$95

+397.4%

Jefferies

Lowest Price Target

$20

+4.7%

UBS

Short Interest

13.5%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 7, 2026	Barclays	Christopher Pasquale—	+57.1%	$30	Initiate	Overweight
Aug 5, 2026	TD Cowen	Joshua Jennings—	+46.6%	$34 → $28	Maintained	Buy
Aug 5, 2026	Piper Sandler	Matt O'Brien—	+30.9%	$35 → $25	Maintained	Overweight
Aug 5, 2026	Evercore ISI Group	Vijay Kumar—	+20.4%	$30 → $23	Maintained	Outperform
Aug 5, 2026	William Blair	Brandon Vazquez—	—	—	Downgrade	Outperform→Market Perform
Jul 28, 2026	UBS	Danielle Antalffy—	+4.7%	$20	Assumes	Buy→Neutral
Jul 6, 2026	Truist Securities	Richard Newitter—	+30.9%	$30 → $25	Downgrade	Buy→Hold
Jun 24, 2026	Evercore ISI Group	Vijay Kumar—	+57.1%	$30	Initiate	Outperform
Jun 11, 2026	Leerink Partners	Mike Kratky—	+51.8%	$31 → $29	Downgrade	Outperform→Market Perform
Apr 30, 2026	Piper Sandler	Matt O'Brien—	+83.2%	$28 → $35	Maintained	Overweight
Mar 6, 2026	Baird	David Rescott—	+57.1%	$30	Initiate	Neutral
Mar 2, 2026	Truist Securities	Richard Newitter—	+57.1%	$47 → $30	Maintained	Buy
Feb 26, 2026	Leerink Partners	Mike Kratky—	+57.1%	$55 → $30	Maintained	Outperform
Feb 26, 2026	TD Cowen	Joshua Jennings—	+78.0%	$50 → $34	Maintained	Buy
Feb 26, 2026	Oppenheimer	Suraj Kalia—	—	—	Downgrade	Outperform→Perform
Feb 26, 2026	Piper Sandler	Matt O'Brien—	+46.6%	$50 → $28	Maintained	Overweight
Feb 26, 2026	Wells Fargo	Nathan Treybeck—	+78.0%	$51 → $34	Maintained	Overweight
Feb 26, 2026	B of A Securities	Craig Bijou—	+4.7%	$38 → $20	Downgrade	Neutral→Underperform
Dec 18, 2025	Truist Securities	Richard Newitter—	+146.1%	$50 → $47	Maintained	Buy
Dec 12, 2025	UBS	Danielle Antalffy—	+224.6%	$62	Initiate	Buy
Dec 8, 2025	B of A Securities	Craig Bijou—	+99.0%	$55 → $38	Downgrade	Buy→Neutral
Dec 2, 2025	Morgan Stanley	Patrick Wood—	+167.0%	$56 → $51	Maintained	Overweight
Nov 5, 2025	TD Cowen	Joshua Jennings—	+161.8%	$85 → $50	Maintained	Buy
Nov 5, 2025	Piper Sandler	Matt O'Brien—	+161.8%	$55 → $50	Maintained	Overweight
Nov 5, 2025	Wells Fargo	Nathan Treybeck—	+167.0%	$58 → $51	Maintained	Overweight